Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen Cash on Hand 2010-2024 | AMGN

Amgen cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Amgen cash on hand for the quarter ending September 30, 2024 was $9.011B, a 74.06% decline year-over-year.
  • Amgen cash on hand for 2023 was $10.944B, a 17.61% increase from 2022.
  • Amgen cash on hand for 2022 was $9.305B, a 15.78% increase from 2021.
  • Amgen cash on hand for 2021 was $8.037B, a 24.51% decline from 2020.
  
Amgen Annual Cash on Hand
(Millions of US $)
2023 $10,944
2022 $9,305
2021 $8,037
2020 $10,647
2019 $8,911
2018 $29,304
2017 $41,678
2016 $38,085
2015 $31,382
2014 $27,026
2013 $19,401
2012 $24,061
2011 $20,641
2010 $17,422
2009 $13,442
Amgen Quarterly Cash on Hand
(Millions of US $)
2024-09-30 $9,011
2024-06-30 $9,301
2024-03-31 $9,708
2023-12-31 $10,944
2023-09-30 $34,741
2023-06-30 $34,248
2023-03-31 $31,561
2022-12-31 $9,305
2022-09-30 $11,478
2022-06-30 $7,183
2022-03-31 $6,544
2021-12-31 $8,037
2021-09-30 $12,921
2021-06-30 $8,082
2021-03-31 $10,566
2020-12-31 $10,647
2020-09-30 $12,360
2020-06-30 $11,421
2020-03-31 $8,012
2019-12-31 $8,911
2019-09-30 $20,853
2019-06-30 $21,758
2019-03-31 $26,301
2018-12-31 $29,304
2018-09-30 $29,921
2018-06-30 $29,395
2018-03-31 $32,172
2017-12-31 $41,678
2017-09-30 $41,351
2017-06-30 $39,227
2017-03-31 $38,398
2016-12-31 $38,085
2016-09-30 $37,980
2016-06-30 $35,034
2016-03-31 $34,740
2015-12-31 $31,382
2015-09-30 $31,120
2015-06-30 $29,993
2015-03-31 $27,118
2014-12-31 $27,026
2014-09-30 $28,075
2014-06-30 $26,188
2014-03-31 $19,802
2013-12-31 $19,401
2013-09-30 $22,558
2013-06-30 $22,018
2013-03-31 $21,271
2012-12-31 $24,061
2012-09-30 $25,374
2012-06-30 $22,475
2012-03-31 $19,374
2011-12-31 $20,641
2011-09-30 $17,676
2011-06-30 $19,172
2011-03-31 $15,358
2010-12-31 $17,422
2010-09-30 $17,049
2010-06-30 $14,523
2010-03-31 $14,117
2009-12-31 $13,442
2009-09-30 $14,013
2009-06-30 $11,965
2009-03-31 $10,378
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $141.575B $28.190B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $116.275B 49.00
Gilead Sciences (GILD) United States $115.367B 20.90
Vertex Pharmaceuticals (VRTX) United States $102.309B 0.00
CSL (CSLLY) Australia $83.807B 0.00
Regeneron Pharmaceuticals (REGN) United States $77.126B 17.56
GSK (GSK) United Kingdom $69.638B 8.06
Argenex SE (ARGX) Netherlands $37.659B 0.00
Alnylam Pharmaceuticals (ALNY) United States $31.657B 0.00
BioNTech SE (BNTX) Germany $27.110B 0.00
Illumina (ILMN) United States $21.573B 78.62
Biogen (BIIB) United States $21.344B 9.17
BeiGene (BGNE) Cayman Islands $17.212B 0.00
Moderna (MRNA) United States $15.158B 0.00
Genmab (GMAB) Denmark $13.441B 19.72
Incyte (INCY) United States $13.262B 0.00
Insmed (INSM) United States $12.602B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.514B 29.05
Bio-Techne Corp (TECH) United States $11.626B 44.89
Sarepta Therapeutics (SRPT) United States $11.364B 102.56
Exact Sciences (EXAS) United States $10.994B 0.00
Vaxcyte (PCVX) United States $10.785B 0.00
QIAGEN (QGEN) Netherlands $10.194B 20.97
Swedish Orphan Biovitrum (BIOVF) Sweden $10.189B 42.09
Exelixis (EXEL) United States $9.507B 21.62
Bio-Rad Laboratories (BIO.B) United States $9.123B 31.00
Intra-Cellular Therapies (ITCI) United States $8.847B 0.00
Roivant Sciences (ROIV) United Kingdom $8.422B 0.00
Ascendis Pharma (ASND) Denmark $8.276B 0.00
Repligen (RGEN) United States $8.094B 105.44
Jazz Pharmaceuticals (JAZZ) Ireland $7.434B 7.27
Revolution Medicines (RVMD) United States $7.412B 0.00
Legend Biotech (LEGN) United States $6.224B 0.00
Nuvalent (NUVL) United States $5.984B 0.00
Halozyme Therapeutics (HALO) United States $5.975B 13.49
Cytokinetics (CYTK) United States $5.767B 0.00
Blueprint Medicines (BPMC) United States $5.726B 0.00
Telix Pharmaceuticals (TLX) Australia $5.295B 0.00
TG Therapeutics (TGTX) United States $5.012B 0.00
Alkermes (ALKS) Ireland $4.807B 16.15
Krystal Biotech (KRYS) United States $4.741B 78.49
Viking Therapeutics (VKTX) United States $4.708B 0.00
Axsome Therapeutics (AXSM) United States $4.397B 0.00
Scholar Rock Holding (SRRK) United States $4.192B 0.00
Apellis Pharmaceuticals (APLS) United States $4.131B 0.00
ADMA Biologics Inc (ADMA) United States $4.113B 43.50
Arcellx (ACLX) United States $4.085B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.083B 0.00
Guardant Health (GH) United States $3.913B 0.00
Avidity Biosciences (RNA) United States $3.796B 0.00
Immunovant (IMVT) United States $3.796B 0.00
Biohaven (BHVN) United States $3.667B 0.00
Alvotech (ALVO) Luxembourg $3.591B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.476B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.449B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.414B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.334B 0.00
NovoCure (NVCR) Jersey $3.333B 0.00
Denali Therapeutics (DNLI) United States $3.087B 0.00
Janux Therapeutics (JANX) United States $2.983B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.945B 0.00
Amicus Therapeutics (FOLD) United States $2.928B 0.00
Edgewise Therapeutics (EWTX) United States $2.915B 0.00
Zai Lab (ZLAB) China $2.903B 0.00
Merus (MRUS) Netherlands $2.865B 0.00
Twist Bioscience (TWST) United States $2.846B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.807B 21.63
Vericel (VCEL) United States $2.789B 941.67
Vera Therapeutics (VERA) United States $2.698B 0.00
SpringWorks Therapeutics (SWTX) United States $2.647B 0.00
Kymera Therapeutics (KYMR) United States $2.633B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.495B 0.00
Protagonist Therapeutics (PTGX) United States $2.473B 15.60
Arrowhead Pharmaceuticals (ARWR) United States $2.420B 0.00
Beam Therapeutics (BEAM) United States $2.402B 0.00
Iovance Biotherapeutics (IOVA) United States $2.249B 0.00
IDEAYA Biosciences (IDYA) United States $2.214B 0.00
CG Oncology (CGON) United States $2.180B 0.00
Ligand Pharmaceuticals (LGND) United States $2.166B 54.08
Apogee Therapeutics (APGE) United States $2.148B 0.00
Bavarian Nordic (BVNRY) Denmark $2.119B 12.99
Geron (GERN) United States $2.110B 0.00
NeoGenomics (NEO) United States $2.106B 0.00
WAVE Life Sciences (WVE) Singapore $2.061B 0.00
Akero Therapeutics (AKRO) United States $2.048B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.023B 0.00
Agios Pharmaceuticals (AGIO) United States $2.020B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.993B 0.00
Belite Bio (BLTE) United States $1.980B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.955B 16.25
Disc Medicine (IRON) United States $1.919B 0.00
MannKind (MNKD) United States $1.889B 48.93
ImmunityBio (IBRX) United States $1.826B 0.00
Galapagos (GLPG) Belgium $1.763B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.755B 0.00
Neumora Therapeutics (NMRA) United States $1.753B 0.00
Fortrea Holdings (FTRE) United States $1.728B 55.03
Certara (CERT) United States $1.724B 48.68
Dynavax Technologies (DVAX) United States $1.672B 97.85
Mesoblast (MESO) Australia $1.670B 0.00
Celldex Therapeutics (CLDX) United States $1.668B 0.00
Structure Therapeutics (GPCR) United States $1.598B 0.00
Viridian Therapeutics (VRDN) United States $1.507B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.487B 0.00
Praxis Precision Medicines (PRAX) United States $1.426B 0.00
Arcus Biosciences (RCUS) United States $1.418B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.417B 0.00
Nurix Therapeutics (NRIX) United States $1.405B 0.00
Novavax (NVAX) United States $1.394B 0.00
Travere Therapeutics (TVTX) United States $1.341B 0.00
MiMedx (MDXG) United States $1.337B 35.00
Day One Biopharmaceuticals (DAWN) United States $1.290B 0.00
Arvinas (ARVN) United States $1.270B 0.00
Intellia Therapeutics (NTLA) United States $1.241B 0.00
Spyre Therapeutics (SYRE) United States $1.227B 0.00
Myriad Genetics (MYGN) United States $1.216B 0.00
ANI Pharmaceuticals (ANIP) United States $1.122B 15.29
Syndax Pharmaceuticals (SNDX) United States $1.116B 0.00
Septerna (SEPN) United States $1.078B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.054B 0.00
Gyre Therapeutics (GYRE) United States $1.042B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.014B 0.00
Vir Biotechnology (VIR) United States $1.011B 0.00
Zymeworks (ZYME) United States $0.974B 0.00
Bicara Therapeutics (BCAX) United States $0.957B 0.00
Adaptive Biotechnologies (ADPT) United States $0.943B 0.00
Liquidia Technologies (LQDA) United States $0.939B 0.00
Poseida Therapeutics (PSTX) United States $0.924B 0.00
Nuvation Bio (NUVB) United States $0.902B 0.00
LENZ Therapeutics (LENZ) United States $0.897B 0.00
ArriVent BioPharma (AVBP) United States $0.879B 0.00
Pacira BioSciences (PCRX) United States $0.876B 8.25
Upstream Bio (UPB) United States $0.869B 0.00
Cogent Biosciences (COGT) United States $0.866B 0.00
Replimune (REPL) United States $0.855B 0.00
89BIO (ETNB) United States $0.843B 0.00
AbCellera Biologics (ABCL) Canada $0.842B 0.00
UniQure (QURE) Netherlands $0.828B 0.00
Prothena (PRTA) Ireland $0.819B 0.00
Immatics (IMTX) Germany $0.818B 0.00
Cytek Biosciences (CTKB) United States $0.814B 0.00
Pliant Therapeutics (PLRX) United States $0.804B 0.00
Avid Bioservices (CDMO) United States $0.787B 0.00
Castle Biosciences (CSTL) United States $0.771B 137.65
Anavex Life Sciences (AVXL) United States $0.732B 0.00
Erasca (ERAS) United States $0.718B 0.00
Tyra Biosciences (TYRA) United States $0.708B 0.00
Dianthus Therapeutics (DNTH) United States $0.704B 0.00
Kura Oncology (KURA) United States $0.701B 0.00
Tectonic Therapeutic (TECX) United States $0.700B 0.00
Keros Therapeutics (KROS) United States $0.690B 0.00
Oculis Holding AG (OCS) Switzerland $0.688B 0.00
CARGO Therapeutics (CRGX) United States $0.686B 0.00
Immunome (IMNM) United States $0.685B 0.00
MBX Biosciences (MBX) United States $0.680B 0.00
Cullinan Therapeutics (CGEM) United States $0.675B 0.00
Rapport Therapeutics (RAPP) United States $0.661B 0.00
Entrada Therapeutics (TRDA) United States $0.658B 11.06
Sinovac Biotech (SVA) China $0.645B 0.00
CureVac (CVAC) Germany $0.643B 5.22
Stoke Therapeutics (STOK) United States $0.619B 0.00
Pharming Group (PHAR) Netherlands $0.617B 0.00
GRAIL (GRAL) United States $0.617B 0.00
Mineralys Therapeutics (MLYS) United States $0.614B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.609B 0.00
Arbutus Biopharma (ABUS) United States $0.608B 0.00
Humacyte (HUMA) United States $0.584B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.579B 0.00
Oric Pharmaceuticals (ORIC) United States $0.579B 0.00
Annexon (ANNX) United States $0.557B 0.00
Astria Therapeutics (ATXS) United States $0.540B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.525B 0.00
CorMedix Inc (CRMD) United States $0.520B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.520B 0.00
Sangamo Therapeutics (SGMO) United States $0.515B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.509B 0.00
Terns Pharmaceuticals (TERN) United States $0.498B 0.00
Third Harmonic Bio (THRD) United States $0.488B 0.00
PureTech Health (PRTC) United States $0.486B 0.00
Abivax SA (ABVX) France $0.485B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.485B 0.00
Cartesian Therapeutics (RNAC) United States $0.483B 0.00
MeiraGTx Holdings (MGTX) United States $0.481B 0.00
Celcuity (CELC) United States $0.463B 0.00
Kodiak Sciences (KOD) United States $0.455B 0.00
MaxCyte (MXCT) United States $0.448B 0.00
AnaptysBio (ANAB) United States $0.443B 0.00
Emergent Biosolutions (EBS) United States $0.439B 0.00
Codexis (CDXS) United States $0.430B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.426B 0.00
ChromaDex (CDXC) United States $0.419B 549.00
Arcturus Therapeutics Holdings (ARCT) United States $0.419B 0.00
Zenas BioPharma (ZBIO) United States $0.418B 0.00
Alumis (ALMS) United States $0.417B 0.00
Alpha Teknova (TKNO) United States $0.412B 0.00
IGM Biosciences (IGMS) United States $0.410B 0.00
Aura Biosciences (AURA) United States $0.410B 0.00
Allogene Therapeutics (ALLO) United States $0.392B 0.00
Prime Medicine (PRME) United States $0.380B 0.00
REGENXBIO (RGNX) United States $0.378B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.371B 0.00
Sana Biotechnology (SANA) United States $0.368B 0.00
GH Research (GHRS) Ireland $0.356B 0.00
Design Therapeutics (DSGN) United States $0.354B 0.00
Olema Pharmaceuticals (OLMA) United States $0.350B 0.00
Contineum Therapeutics (CTNM) United States $0.348B 0.00
Absci (ABSI) United States $0.343B 0.00
Sage Therapeutics (SAGE) United States $0.343B 0.00
Northwest Biotherapeutics (NWBO) United States $0.343B 0.00
Kamada (KMDA) Israel $0.339B 21.07
Neurogene (NGNE) United States $0.336B 0.00
Tango Therapeutics (TNGX) United States $0.333B 0.00
Eton Pharmaceuticals (ETON) United States $0.327B 0.00
Jasper Therapeutics (JSPR) United States $0.324B 0.00
Revance Therapeutics (RVNC) United States $0.323B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.321B 0.00
XOMA Royalty (XOMA) United States $0.320B 0.00
ACELYRIN, INC (SLRN) United States $0.316B 0.00
Voyager Therapeutics (VYGR) United States $0.314B 8.10
Trevi Therapeutics (TRVI) United States $0.311B 0.00
Prima BioMed (IMMP) Australia $0.295B 0.00
Foghorn Therapeutics (FHTX) United States $0.286B 0.00
Candel Therapeutics (CADL) United States $0.284B 0.00
ATyr Pharma (ATYR) United States $0.281B 0.00
C4 Therapeutics (CCCC) United States $0.279B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.279B 0.00
DiaMedica Therapeutics (DMAC) United States $0.274B 0.00
ITeos Therapeutics (ITOS) United States $0.271B 0.00
Artiva Biotherapeutics (ARTV) United States $0.270B 0.00
Atea Pharmaceuticals (AVIR) United States $0.269B 0.00
Chimerix (CMRX) United States $0.269B 0.00
Lifecore Biomedical (LFCR) United States $0.267B 0.00
AC Immune (ACIU) Switzerland $0.265B 0.00
Benitec Biopharma (BNTC) United States $0.265B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.260B 0.00
Renovaro (RENB) United States $0.260B 0.00
EnGene Holdings (ENGN) Canada $0.258B 0.00
Rezolute (RZLT) United States $0.254B 0.00
Urogen Pharma (URGN) United States $0.250B 0.00
Abeona Therapeutics (ABEO) United States $0.248B 0.00
BioStem Technologies (BSEM) $0.240B 21.24
Anika Therapeutics (ANIK) United States $0.239B 0.00
Fulcrum Therapeutics (FULC) United States $0.235B 0.00
Ocugen (OCGN) United States $0.226B 0.00
Precigen (PGEN) United States $0.223B 0.00
Nautilus Biotechnology (NAUT) United States $0.221B 0.00
BioAge Labs (BIOA) United States $0.220B 0.00
Cardiff Oncology (CRDF) United States $0.218B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.215B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.214B 0.00
Inhibrx Biosciences (INBX) United States $0.211B 0.00
Molecular Partners AG (MOLN) Switzerland $0.205B 0.00
Mersana Therapeutics (MRSN) United States $0.198B 0.00
Opthea (OPT) Australia $0.195B 0.00
XBiotech (XBIT) United States $0.194B 0.00
Inozyme Pharma (INZY) United States $0.192B 0.00
Fate Therapeutics (FATE) United States $0.191B 0.00
Gossamer Bio (GOSS) United States $0.190B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
Compass Therapeutics (CMPX) United States $0.190B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.190B 0.00
TuHURA Biosciences (HURA) United States $0.189B 0.00
Amarin (AMRN) Ireland $0.189B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.187B 0.00
Verastem (VSTM) United States $0.186B 0.00
Checkpoint Therapeutics (CKPT) United States $0.183B 0.00
Alector (ALEC) United States $0.182B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.176B 0.00
Coherus BioSciences (CHRS) United States $0.175B 0.00
Semper Paratus Acquisition (TVGN) United States $0.174B 0.00
Kyverna Therapeutics (KYTX) United States $0.173B 0.00
Bright Minds Biosciences (DRUG) United States $0.171B 0.00
Innate Pharma S.A (IPHA) France $0.170B 0.00
ScPharmaceuticals (SCPH) United States $0.170B 0.00
Elutia (ELUT) United States $0.167B 0.00
Nkarta (NKTX) United States $0.167B 0.00
Solid Biosciences (SLDB) United States $0.166B 0.00
Adherex Technologies (FENC) United States $0.165B 0.00
Cidara Therapeutics (CDTX) United States $0.164B 0.00
Caribou Biosciences (CRBU) United States $0.163B 0.00
Greenwich LifeSciences (GLSI) United States $0.163B 0.00
2seventy Bio (TSVT) United States $0.162B 0.00
TScan Therapeutics (TCRX) United States $0.159B 0.00
Ventyx Biosciences (VTYX) United States $0.158B 0.00
Seres Therapeutics (MCRB) United States $0.156B 0.00
Sutro Biopharma (STRO) United States $0.155B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.155B 0.00
Biomea Fusion (BMEA) United States $0.153B 0.00
Sagimet Biosciences (SGMT) United States $0.152B 0.00
Zura Bio (ZURA) United States $0.149B 0.00
Aligos Therapeutics (ALGS) United States $0.143B 0.00
Compugen (CGEN) Israel $0.137B 76.50
Monopar Therapeutics (MNPR) United States $0.136B 0.00
Seer (SEER) United States $0.136B 0.00
Puma Biotechnology (PBYI) United States $0.135B 5.73
Instil Bio (TIL) United States $0.135B 0.00
Tenaya Therapeutics (TNYA) United States $0.132B 0.00
Actuate Therapeutics (ACTU) United States $0.132B 0.00
InflaRx (IFRX) Germany $0.132B 0.00
Climb Bio (CLYM) United States $0.131B 0.00
Black Diamond Therapeutics (BDTX) United States $0.126B 0.00
Akoya Biosciences (AKYA) United States $0.123B 0.00
Inventiva S.A (IVA) France $0.123B 0.00
PepGen (PEPG) United States $0.118B 0.00
Cabaletta Bio (CABA) United States $0.116B 0.00
Invizyne Technologies (IZTC) United States $0.116B 0.00
TELA Bio (TELA) United States $0.112B 0.00
Leap Therapeutics (LPTX) United States $0.112B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.111B 0.00
Editas Medicine (EDIT) United States $0.108B 0.00
Allakos (ALLK) United States $0.107B 0.00
Abpro Holdings (ABP) United States $0.107B 0.00
MediciNova (MNOV) United States $0.106B 0.00
Alto Neuroscience (ANRO) United States $0.105B 0.00
CAMP4 Therapeutics (CAMP) United States $0.105B 0.00
X4 Pharmaceuticals (XFOR) United States $0.104B 0.00
BioHarvest Sciences (BHST) Canada $0.103B 0.00
Applied Therapeutics (APLT) United States $0.102B 0.00
Adverum Biotechnologies (ADVM) United States $0.099B 0.00
INmune Bio (INMB) United States $0.098B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.096B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Genenta Science S.p.A (GNTA) Italy $0.092B 0.00
Cellectis S.A (CLLS) France $0.091B 0.00
Adagene (ADAG) China $0.091B 0.00
Immunic (IMUX) United States $0.090B 0.00
Coya Therapeutics (COYA) United States $0.088B 0.00
Nuvectis Pharma (NVCT) United States $0.087B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.087B 0.00
Scilex Holding (SCLX) United States $0.086B 0.00
ALX Oncology Holdings (ALXO) United States $0.085B 0.00
23andMe Holding (ME) United States $0.085B 0.00
CytomX Therapeutics (CTMX) United States $0.085B 6.41
Aadi Bioscience (AADI) United States $0.084B 0.00
Bluebird Bio (BLUE) United States $0.083B 0.00
Theratechnologies (THTX) Canada $0.082B 0.00
Skye Bioscience (SKYE) United States $0.082B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.082B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.082B 0.00
Rani Therapeutics Holdings (RANI) United States $0.080B 0.00
Adlai Nortye (ANL) Cayman Islands $0.080B 0.00
Generation Bio (GBIO) United States $0.079B 0.00
Genelux (GNLX) United States $0.078B 0.00
Quince Therapeutics (QNCX) United States $0.078B 0.00
FibroBiologics (FBLG) United States $0.078B 0.00
Alpha Cognition (ACOG) Canada $0.077B 0.00
I-Mab (IMAB) China $0.075B 0.00
Entera Bio (ENTX) Israel $0.075B 0.00
Adicet Bio (ACET) United States $0.075B 0.00
Ikena Oncology (IKNA) United States $0.075B 0.00
Aerovate Therapeutics (AVTE) United States $0.073B 0.00
Ovid Therapeutics (OVID) United States $0.071B 0.00
Werewolf Therapeutics (HOWL) United States $0.071B 0.00
VistaGen Therapeutics (VTGN) United States $0.070B 0.00
Vigil Neuroscience (VIGL) United States $0.070B 0.00
ZIVO Bioscience (ZIVO) United States $0.067B 0.00
Agenus (AGEN) United States $0.066B 0.00
Clearside Biomedical (CLSD) United States $0.066B 0.00
Atara Biotherapeutics (ATRA) United States $0.066B 0.00
DBV Technologies S.A (DBVT) France $0.066B 0.00
Oncolytics Biotech (ONCY) Canada $0.064B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.064B 0.00
Cue Biopharma (CUE) United States $0.064B 0.00
Galena Biopharma (SLS) United States $0.063B 0.00
Immuneering (IMRX) United States $0.062B 0.00
BeyondSpring (BYSI) United States $0.062B 0.00
PDS Biotechnology (PDSB) United States $0.062B 0.00
BGM Group (BGM) China $0.061B 0.00
Annovis Bio (ANVS) United States $0.060B 0.00
Immix Biopharma (IMMX) United States $0.060B 0.00
Vor Biopharma (VOR) $0.060B 0.00
Kronos Bio (KRON) United States $0.058B 0.00
Boundless Bio (BOLD) United States $0.058B 0.00
Xilio Therapeutics (XLO) United States $0.056B 0.00
Repare Therapeutics (RPTX) Canada $0.056B 0.00
Shattuck Labs (STTK) United States $0.055B 0.00
Invivyd (IVVD) United States $0.053B 0.00
Elicio Therapeutics (ELTX) United States $0.053B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.053B 0.00
Connect Biopharma Holdings (CNTB) United States $0.053B 0.00
Spero Therapeutics (SPRO) United States $0.052B 13.64
Dyadic (DYAI) United States $0.052B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.052B 0.00
Celularity (CELU) United States $0.051B 0.00
IO Biotech (IOBT) Denmark $0.051B 0.00
Exicure (XCUR) United States $0.049B 0.00
Inovio Pharmaceuticals (INO) United States $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Fortress Biotech (FBIO) United States $0.047B 0.00
Kezar Life Sciences (KZR) United States $0.047B 0.00
Omega Therapeutics (OMGA) United States $0.046B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.045B 0.00
Q32 Bio (QTTB) United States $0.044B 0.00
SAB Biotherapeutics (SABS) United States $0.043B 0.00
Estrella Immunopharma (ESLA) United States $0.042B 0.00
Passage Bio (PASG) United States $0.041B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.040B 0.00
Enzo Biochem (ENZ) United States $0.040B 0.00
Rallybio (RLYB) United States $0.039B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.039B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.039B 0.00
Lexaria Bioscience (LEXX) Canada $0.039B 0.00
Grace Therapeutics (GRCE) Canada $0.039B 0.00
Aileron Therapeutics (ALRN) United States $0.038B 0.00
AN2 Therapeutics (ANTX) United States $0.038B 0.00
CalciMedica (CALC) United States $0.037B 0.00
Clene (CLNN) United States $0.037B 0.00
Precision BioSciences (DTIL) United States $0.036B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Elevation Oncology (ELEV) United States $0.034B 0.00
Oncobiologics (OTLK) United States $0.034B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
BioAtla (BCAB) United States $0.033B 0.00
Opus Genetics (IRD) United States $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
RenovoRx (RNXT) United States $0.030B 0.00
Beyond Air (XAIR) United States $0.029B 0.00
Rapt Therapeutics (RAPT) United States $0.029B 0.00
Intensity Therapeutics (INTS) United States $0.028B 0.00
Forte Biosciences (FBRX) United States $0.028B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.028B 0.00
OnKure Therapeutics (OKUR) United States $0.028B 0.00
Medicus Pharma (MDCX) Canada $0.028B 0.00
LakeShore Biopharma (LSB) China $0.028B 0.00
KALA BIO (KALA) United States $0.027B 0.00
NextCure (NXTC) United States $0.027B 0.00
Cadrenal Therapeutics (CVKD) United States $0.027B 0.00
Pluri (PLUR) Israel $0.027B 0.00
Cognition Therapeutics (CGTX) United States $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.026B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.026B 0.00
Femasys (FEMY) United States $0.025B 0.00
BRIACELL THERAP (BCTX) Canada $0.025B 0.00
Longeveron (LGVN) United States $0.024B 0.00
Gelteq (GELS) Australia $0.024B 0.00
HOOKIPA Pharma (HOOK) United States $0.024B 0.00
Chemomab Therapeutics (CMMB) Israel $0.024B 0.00
Dare Bioscience (DARE) United States $0.024B 0.00
Cara Therapeutics (CARA) United States $0.023B 0.00
Ocean Biomedical (OCEA) United States $0.023B 0.00
Cocrystal Pharma (COCP) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
NKGen Biotech (NKGN) United States $0.023B 0.00
Athira Pharma (ATHA) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
GeoVax Labs (GOVX) United States $0.022B 0.00
Equillium (EQ) United States $0.022B 0.00
MiNK Therapeutics (INKT) United States $0.021B 0.00
Bionano Genomics (BNGO) United States $0.020B 0.00
Affimed (AFMD) Germany $0.019B 0.00
Bolt Biotherapeutics (BOLT) United States $0.019B 0.00
Tenax Therapeutics (TENX) United States $0.019B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.019B 0.00
Senti Biosciences (SNTI) United States $0.018B 0.00
Cyclo Therapeutics (CYTH) United States $0.018B 0.00
IN8bio (INAB) United States $0.018B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.018B 0.00
HCW Biologics (HCWB) United States $0.017B 0.00
Aptose Biosciences (APTO) Canada $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Aprea Therapeutics (APRE) United States $0.017B 0.00
Spruce Biosciences (SPRB) United States $0.017B 0.00
UNITY Biotechnology (UBX) United States $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
Pieris Pharmaceuticals (PVLA) United States $0.016B 0.00
BioAffinity Technologies (BIAF) United States $0.015B 0.00
BioXcel Therapeutics (BTAI) United States $0.015B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
CervoMed (CRVO) United States $0.014B 0.00
Mainz Biomed (MYNZ) Germany $0.013B 0.00
Cingulate (CING) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Apollomics (APLM) United States $0.011B 0.00
Ensysce Biosciences (ENSC) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.009B 0.00
BioCardia (BCDA) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Aytu BioPharma (AYTU) United States $0.008B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Soligenix (SNGX) United States $0.007B 0.00
Eyenovia (EYEN) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Vincerx Pharma (VINC) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Elevai Labs (ELAB) United States $0.007B 0.00
GRI Bio (GRI) United States $0.007B 0.00
Polyrizon (PLRZ) Israel $0.007B 0.00
Portage Biotech (PRTG) $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Galecto (GLTO) Denmark $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.006B 0.00
Quantum Biopharma (QNTM) Canada $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Evaxion Biotech (EVAX) Denmark $0.005B 0.00
Syros Pharmaceuticals (SYRS) United States $0.005B 0.00
Moleculin Biotech (MBRX) United States $0.005B 0.00
Carmell (CTCX) United States $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Allarity Therapeutics (ALLR) United States $0.004B 0.00
Bionomics (BNOX) Australia $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
AquaBounty Technologies (AQB) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00